Chief Executive Officer
Nick joined the Board as an advisor following the acquisition of BresMed by Arsenal Capital Partners in February 2020. He became Chief Executive Officer of BresMed in December 2020.
Before becoming CEO of BresMed, Nick was Senior Vice President of Arsenal Capital Partners’ Value Demonstration Platform. Nick provided acquired companies with support to achieve success in their next chapter and as integral parts of the overall enterprise.
Nick has spent most of his career in value and access consulting, beginning two decades ago with pioneering independent firm the Total Healthcare Group. Before joining Arsenal Capital Partners, Nick was on the executive team at Evidera as Senior Vice President of Market Access, leading teams of ~80 experts. Nick was part of the group that led the creation of Evidera from United BioSource Corporation with the support of a leading private equity firm.
Nick studied Zoology at the University of Wales, before a master’s degree at the London School of Hygiene and Tropical Medicine.
Nick is based in the Brecon Beacons, south east Wales, where he enjoys spending as much time outside, cycling, walking and learning how to garden.
What Nick says about BresMed: “I’ve admired BresMed from the outside as a competitor for many years. It’s now a privilege to be part of the family and seeing great people and cutting-edge science do great things for our clients.”
2020-Present Chief Executive Officer BresMed
2020 Senior Vice President Arsenal Capital Partners’ Value Demonstration Platform
2016-2018 Senior Vice President, Market Access & Medical Writing Evidera, a PPD Company
2014-2016 Senior Vice President, Market Access Evidera, a Symphony Technology Group Company
2013-2014 Senior Vice President, Payer Communications Evidera, a Symphony Technology Group Company
2010-2013 Director, Global Market Access Communications United BioSource Corporation
1999-2010 Associate Director Total Healthcare Group